These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 65494)

  • 21. [Antibacterial activity of Enviomycin for atypical mycobacteria. 2. Animal experiments (author's transl)].
    Toyohara M
    Kekkaku; 1979 Sep; 54(9):461-5. PubMed ID: 502153
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anti-bacterial activity of capreomycin, kanamycin, or viomycin against drug-resistant tubercle bacilli isolated from patients].
    Endo K
    Jpn J Antibiot; 1971 Jun; 24(3):149-51. PubMed ID: 4327336
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cross-resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M; Toyama H; Mizuno S; Tsukamura S
    Kekkaku; 1967 Oct; 42(10):399-404. PubMed ID: 4295935
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on lividomycin. I. In vitro antibacterial activities of LVDM against clinical isolates of Mycobacterium tuberculosis.
    Shimizu T
    Jpn J Antibiot; 1974 Dec; 27(6):766-74. PubMed ID: 4142798
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experimental studies in vitro on the antituberculous activities of tuberactinomycin (TUM) and tuberactinomycin-N (TUM-N) (author's transl)].
    Maekawa N; Ikeda N; Oda Y; Uratsuji Y; Inagake H
    Kekkaku; 1977 May; 52(5):211-8. PubMed ID: 407391
    [No Abstract]   [Full Text] [Related]  

  • 26. Study on tuberactinomycin-N. I. In vitro Antibacterial activity of TUM-N on Tubercle bacilli isolated from patients.
    Shimizu T
    Jpn J Antibiot; 1974 Aug; 27(4):463-70. PubMed ID: 4140247
    [No Abstract]   [Full Text] [Related]  

  • 27. [In vitro susceptibility testing of nontuberculous mycobacteria to streptomycin, kanamycin and enviomycin].
    Tsukamura M
    Kekkaku; 1989 Sep; 64(9):557-62. PubMed ID: 2554046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin].
    Makarevich NM; Mkrtchian SV; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):345-51. PubMed ID: 4321321
    [No Abstract]   [Full Text] [Related]  

  • 29. Cross-resistance relationships between capreomycin, kanamycin, and viomycin resistances in tubecle bacilli from paients.
    Tsukamura M
    Am Rev Respir Dis; 1969 May; 99(5):780-2. PubMed ID: 4306213
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experimental and clinical study test of capreomycin].
    Kozlova NV; Dzhumaev B; Stepanian ES; Kaminskaia GO
    Antibiotiki; 1976 Jul; 21(7):650-4. PubMed ID: 60080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antimycobacterial activity of capreomycin.
    Lucchesi M
    Antibiot Chemother; 1970; 16():27-31. PubMed ID: 4108891
    [No Abstract]   [Full Text] [Related]  

  • 32. [In vitro antituberculous activity of lividomycin].
    Kobayashi F; Nagoya T; Eda J; Yoshimura Y
    Jpn J Antibiot; 1972 Dec; 25(6):360-6. PubMed ID: 4125073
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on the effect of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). I. Studies in vitro].
    Ota Y
    Kekkaku; 1971 Aug; 46(8):295-301. PubMed ID: 4328204
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on resistance of tubercle bacilli to reserve drugs. II. Resistance to viomycin and kanamycin in experimenta tuberculosis in guinea pigs].
    Janowiec M
    Gruzlica; 1966 Oct; 34(10):903-6. PubMed ID: 4292274
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of rifandin on ultrastructure of tubercle bacilli.
    Mei GH; Cheng DE; Deng HF; Wang XL; Zhang TM
    Chin Med J (Engl); 1985 Aug; 98(8):603-6. PubMed ID: 3937689
    [No Abstract]   [Full Text] [Related]  

  • 36. [Activities of rifampicin, capreomycin, viomycin or kanamycin against Mycobacterium tuberculosis isolated from tuberculosis patients].
    Endo K
    Jpn J Antibiot; 1970 Aug; 23(4):387-9. PubMed ID: 4321638
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antibacterial activity of enviomycin for atypical mycobacteria. 1. Antibacterial activity in vitro (author's transl)].
    Toyohara M
    Kekkaku; 1978 Apr; 53(4):255-60. PubMed ID: 661057
    [No Abstract]   [Full Text] [Related]  

  • 38. Experimental studies on the combined effect of kanamycin and viomycin.
    Hokama S
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):62-9. PubMed ID: 4320009
    [No Abstract]   [Full Text] [Related]  

  • 39. [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro].
    Mkrtchian SV
    Antibiotiki; 1968 Oct; 13(10):907-10. PubMed ID: 4303355
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin.
    Akbergenov R; Shcherbakov D; Matt T; Duscha S; Meyer M; Wilson DN; Böttger EC
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4712-7. PubMed ID: 21768509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.